Has the survival of the heart failure population changed? Lessons from trials. (Q33544360)

27 July 2017

1 reference

title

Has the survival of the heart failure population changed? Lessons from trials. (English)

1 reference

27 July 2017

0 references

Cleland JG

1

1 reference

27 July 2017

Clark A

series ordinal

2

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

American Journal of Cardiology

27 July 2017

published in

1 reference

27 July 2017

volume

83

1 reference

27 July 2017

issue

5B

1 reference

27 July 2017

page(s)

112D-119D

1 reference

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Beta-blocking agents in heart failure. Should they be used and how?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Successes and failures of current treatment of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Survival after the onset of congestive heart failure in Framingham Heart Study subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Validity of clinical diagnosis of heart failure in primary health care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Anticoagulant and antiplatelet therapy in heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Recognising the limits of randomized clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Costs and effects of enalapril therapy in patients with symptomatic heart failure: an economic analysis of the Studies of Left Ventricular Dysfunction (SOLVD) Treatment Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Mode of death in chronic heart failure. A request and proposition for more accurate classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990. Multinational MONItoring of Trends and Determinants in CArdiovascular Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

The effect of digoxin on mortality and morbidity in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Should all patients with atrial fibrillation receive warfarin? Evidence from randomized clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Is aspirin safe for patients with heart failure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Clinical characteristics and mortality of patients screened for entry into the Trandolapril Cardiac Evaluation (TRACE) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Course and prognosis in patients > or = 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Angiotensin-converting-enzyme inhibitors in the management of cardiac failure: are we ignoring the evidence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Changing patterns of investigation and treatment of cardiac failure in hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

Risk stratification in chronic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901011-X

10.1016/S0002-9149(98)01011-X

7 January 2021

Identifiers

DOI

1 reference

27 July 2017

1 reference